Medications for Rheumatoid Arthritis

36 results
  • abrilada - adalimumab - afzb

    (Adalimumab-Afzb)
    Pfizer Laboratories Div Pfizer Inc
    Abrilada is a TNF blocker indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis (age 2+), Crohn's disease (age 6+), ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults.
  • actemra - tocilizumab injection, solution, concentrate

    (Tocilizumab)
    Genentech, Inc.
    Actemra (tocilizumab) treats moderately to severely active rheumatoid arthritis, giant cell arteritis, SSc-associated interstitial lung disease, polyarticular and systemic juvenile idiopathic arthritis (ages 2+), CAR T cell-induced cytokine release syndrome, and hospitalized COVID-19 patients requiring oxygen support or mechanical ventilation.
  • acthar - repository corticotropin injection

    (Repository Corticotropin)
    Mallinckrodt Ard Llc
    Acthar Gel treats infantile spasms in children under 2 and acute multiple sclerosis exacerbations in adults. Also indicated for rheumatic, collagen, dermatologic, allergic, ophthalmic, and respiratory disorders, and nephrotic syndrome edema.
  • amjevita - adalimumab - atto injection

    (Adalimumab-Atto)
    Amgen Inc
    TNF blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and eligible pediatric patients.
  • avsola - infliximab - axxq injection, powder, lyophilized, for solution

    (Infliximab-Axxq)
    Amgen, Inc
    Avsola is a TNF blocker for moderately to severely active Crohn's disease and ulcerative colitis (adults and children ≥6 years), rheumatoid arthritis (with methotrexate), ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis in adults.
  • celebrex - celecoxib capsule

    (Celecoxib)
    Viatris Specialty Llc
    Celebrex is indicated for managing signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (ages 2+), and ankylosing spondylitis. It is also used for acute pain management in adults and primary dysmenorrhea.
  • cimzia - certolizumab pegol

    (Certolizumab Pegol)
    Ucb, Inc.
    CIMZIA is a TNF blocker that treats moderately to severely active Crohn's disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and plaque psoriasis in adults, and polyarticular juvenile idiopathic arthritis in patients 2 years and older.
  • cyltezo - adalimumab - adbm

    (Adalimumab-Adbm)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Cyltezo is a TNF blocker indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, non-infectious uveitis in adults, and juvenile idiopathic arthritis and uveitis in pediatric patients.
  • enbrel - etanercept

    (Etanercept)
    Immunex Corporation
    Enbrel is a TNF blocker for adults with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis; and for children 2+ with polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis, and children 4+ with plaque psoriasis.